Please find enclosed copies of newspaper cuttings of the extract of Statement of Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GKB Ophthalmics Ltd submitted newspaper cuttings of its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, published in Free Press Journal (Mumbai) and Pudhari (Marathi) on February 14, 2026. The board meeting approving these results was held on February 12, 2026. Standalone revenue from operations for Q3 FY26 stood at around ₹436 lakhs, with profit after tax of approximately ₹66.50 lakhs, compared to a loss of about ₹50.47 lakhs in Q3 FY25 — indicating a clear turnaround. On a consolidated basis, Q3 FY26 net profit was around ₹194 lakhs versus roughly ₹53 lakhs in Q3 FY25. For 9M FY26, standalone PAT was approximately ₹205 lakhs versus a loss of around ₹172 lakhs in 9M FY25, while standalone EPS for the quarter was ₹0.88.
The company has swung back to profitability on both standalone and consolidated bases in Q3 FY26 with strong year-on-year profit growth, which is a positive signal for shareholders and could lift investor sentiment around the stock.